Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Hedgehog-signalling cooperates with PI3K-signalling during transformation of the mammary gland

FY 2017-18

Summary
This study investigates molecular mechanisms involved in the transformation of the mammary gland, or breast, using a mouse model possessing a recessive mutation in the Patched-1 (Ptch1) gene. Patched-1 is a transmembrane receptor protein required for repression of Smoothened (Smo) activity in the Hedgehog (Hh)-signalling pathway, a fundamental developmental pathway. Dysregulation of this pathway has been implicated in a number of cancers, including breast cancer.We have determined that this mutation in Ptch1 prevents the development of the mammary gland in mice during puberty, without interruption of 'canonical' Hh-signalling through Smo. Therefore, this suggests 'non-canonical' Hh-signalling, operating independent of Smo, is crucial for normal mammary gland development. Interestingly, in mice with this mutation the effects of potent oncogenes, such as ErbB2 and c-src, are altered. Collectively, our studies suggest the presence of a novel network of interacting molecules, involving Ptch1, are imperative for normal breast development. Thus, I hypothesize that a 'non-canonical' Hh-pathway involving Ptch1, in cooperation with interacting molecules, affects the ability of p110-alpha, a gene found mutated in numerous human breast cancers, to produce tumours.To address this hypothesis, transgenic mice with mutations in the pathways controlled by Ptch-1 and p110-alpha, the Hh and PI3K pathways, respectively, coupled with molecular-genetic in-vitro experiments, will be used to observe how these pathways interact to cause breast cancer. Taken together, these studies will provide insight into a novel interaction between two 'druggable' pathways (Hh and PI3K), and how these two pathways cooperate to produce breast cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386436
Name
Gjelaj Ersa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hedgehog-signalling cooperates with PI3K-signalling during transformation of the mammary gland
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Developmental Pathway; Hh-Pathway; Mammary Gland; Patched-1; Pi3k-Pathway; Transgenic Mice
Abstract
This study investigates molecular mechanisms involved in the transformation of the mammary gland, or breast, using a mouse model possessing a recessive mutation in the Patched-1 (Ptch1) gene. Patched-1 is a transmembrane receptor protein required for repression of Smoothened (Smo) activity in the Hedgehog (Hh)-signalling pathway, a fundamental developmental pathway. Dysregulation of this pathway has been implicated in a number of cancers, including breast cancer.We have determined that this mutation in Ptch1 prevents the development of the mammary gland in mice during puberty, without interruption of 'canonical' Hh-signalling through Smo. Therefore, this suggests 'non-canonical' Hh-signalling, operating independent of Smo, is crucial for normal mammary gland development. Interestingly, in mice with this mutation the effects of potent oncogenes, such as ErbB2 and c-src, are altered. Collectively, our studies suggest the presence of a novel network of interacting molecules, involving Ptch1, are imperative for normal breast development. Thus, I hypothesize that a 'non-canonical' Hh-pathway involving Ptch1, in cooperation with interacting molecules, affects the ability of p110-alpha, a gene found mutated in numerous human breast cancers, to produce tumours.To address this hypothesis, transgenic mice with mutations in the pathways controlled by Ptch-1 and p110-alpha, the Hh and PI3K pathways, respectively, coupled with molecular-genetic in-vitro experiments, will be used to observe how these pathways interact to cause breast cancer. Taken together, these studies will provide insight into a novel interaction between two 'druggable' pathways (Hh and PI3K), and how these two pathways cooperate to produce breast cancer.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gjelaj, Ersa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~